Landmark Victory For Western Company In Chinese IP Court

A six-year long IP dispute that had reached the Supreme People’s Court in China resulted in a victory for a Danish biotech company against two Chinese competitors. This is a case “of a foreign company prevailing in a sector in which the Chinese government has given significant support to local companies in an effort to build up its domestic industry,” writes iam magazine blogger Jacob Shindler. “The rare ruling by the Supreme People’s Court in this technology area is good news for biotech innovators.” The ruling came after the Danish company, Novozymes, had accused its Chinese competitors of infringement and won a succession of judgments. They two companies then challenged the validity of the Danish company’s patent, and lost.